Boehringer Ingelheim is expanding its $77 million contract biologics China plant, making a notable bet that the kind of contract services it offers elsewhere will be a big draw to China too.
Viscofan BioEngineering, a German medical products manufacturer is to conduct a Phase I clinical trial of its stem cell implant, VB-C01, designed to treat severe cardiac insufficiencies, on receiving a green light from the Spanish Agency for Medicines (AEMPS).
Hepatitis C is caused by the Hepatitis C virus (HCV), which affects the liver. The World Health Organization (WHO) reported that around 399,000 people die every year due to Hepatitis C throughout the world. Hepatitis C leads to cirrhosis and liver cancer since it is diagnosed only at a late stage.
The Dubai Health Authority (DHA) announced free Hepatitis C screening and treatment under the health plan of the Dubai Mandatory Health Insurance Scheme on 9 July 2018.
A research team from Tel Aviv University suggested that red wine and green tea could treat certain congenital metabolic diseases, by blocking toxic metabolite formations. Since people with inborn metabolic disorders are born with a defective gene, it leads to a critical enzyme deficiency. Since there is no cure, many patients with congenital metabolic disorders are required to follow a lifelong strict diet.
The smart bandages used in this research work were designed with heating elements and thermo-responsive drug carriers in order to deliver timely treatments. It combines both temperature and pH sensors to track the signs of infection.
A recent survey from Intel revealed that health system decision-makers have considered artificial intelligence as a new element of life. Still, many people are anxious as to whether it could provide safe care.
The FDA sent a warning letter to Sichuan Friendly Pharmaceutical after listing it in the import alert list due to its abysmal performance during a fall inspection. The FDA was not pleased with the manufacturing methods it saw at the Chinese API maker’s facility.
In a breakthrough finding, revealed through the final analysis of a mid-stage trial, Japanese pharmaceutical firm, Eisai Co and Biogen Inc’s drug for Alzheimer’s proved beneficial for patients who received the highest dose.
Baclofen, which was once used to treat spasticity, has started seeing an increase as a prescription for alcohol use disorders. The advantage of Baclofen is that it could be discharged easily through the kidneys to a great extent. Scientists addressed it as a wonder drug due to its effective treatment for alcoholism.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.